Literature DB >> 19875703

Kupffer cell activation is a causal factor for hepatic insulin resistance.

Nicolas Lanthier1, Olivier Molendi-Coste, Yves Horsmans, Nico van Rooijen, Patrice D Cani, Isabelle A Leclercq.   

Abstract

Recruited adipose tissue macrophages contribute to chronic and low-grade inflammation causing insulin resistance in obesity. Similarly, we hypothesized here that Kupffer cells, the hepatic resident macrophages, play a pathogenic role in hepatic insulin resistance induced by a high-fat diet. Mice were fed a normal diet or high-fat diet for 3 days. Kupffer cell activation was evaluated by immunohistochemistry and quantitative RT-PCR. Insulin sensitivity was assessed in vivo by hyperinsulinemic-euglycemic clamp and insulin-activated signaling was investigated by Western blot. Liposome-encapsulated clodronate was injected intravenously to deplete macrophages prior to a short-term exposure to high-fat diet. Here, we characterized a short-term high-fat diet model in mice and demonstrated early hepatic insulin resistance and steatosis concurrent with Kupffer cell activation. We demonstrated that selective Kupffer cell depletion obtained by intravenous clodronate, without affecting adipose tissue macrophages, was sufficient to enhance insulin-dependent insulin signaling and significantly improve hepatic insulin sensitivity in vivo in this short-term high-fat diet model. Our study clearly shows that hepatic macrophage response participates to the onset of high-fat diet-induced hepatic insulin resistance and may therefore represent an attractive target for prevention and treatment of diet- and obesity-induced insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19875703     DOI: 10.1152/ajpgi.00391.2009

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  109 in total

Review 1.  Mechanisms of inflammatory responses in obese adipose tissue.

Authors:  Shengyi Sun; Yewei Ji; Sander Kersten; Ling Qi
Journal:  Annu Rev Nutr       Date:  2012-03-09       Impact factor: 11.848

Review 2.  Inflammatory mechanisms linking obesity and metabolic disease.

Authors:  Alan R Saltiel; Jerrold M Olefsky
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

3.  The IGF2 mRNA binding protein p62/IGF2BP2-2 induces fatty acid elongation as a critical feature of steatosis.

Authors:  Stephan Laggai; Sonja M Kessler; Stefan Boettcher; Valérie Lebrun; Katja Gemperlein; Eva Lederer; Isabelle A Leclercq; Rolf Mueller; Rolf W Hartmann; Johannes Haybaeck; Alexandra K Kiemer
Journal:  J Lipid Res       Date:  2014-04-22       Impact factor: 5.922

4.  Reply: To PMID 23996730.

Authors:  Ling Yang; Ekihiro Seki
Journal:  Hepatology       Date:  2014-07-28       Impact factor: 17.425

5.  Serum-inducible protein (IP)-10 is a disease progression-related marker for non-alcoholic fatty liver disease.

Authors:  Nozomu Wada; Akinobu Takaki; Fusao Ikeda; Tetsuya Yasunaka; Masahiro Onji; Kazuhiro Nouso; Atsuko Nakatsuka; Jun Wada; Kazuko Koike; Koji Miyahara; Hidenori Shiraha; Kazuhide Yamamoto; Hiroyuki Okada
Journal:  Hepatol Int       Date:  2016-11-08       Impact factor: 6.047

Review 6.  Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics.

Authors:  Julio Plaza-Diaz; Carolina Gomez-Llorente; Luis Fontana; Angel Gil
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

Review 7.  The cellular and signaling networks linking the immune system and metabolism in disease.

Authors:  Olivia Osborn; Jerrold M Olefsky
Journal:  Nat Med       Date:  2012-03-06       Impact factor: 53.440

8.  Targeting Kupffer cells in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why and how?

Authors:  Nicolas Lanthier
Journal:  World J Hepatol       Date:  2015-09-08

Review 9.  Kupffer Cells: Inflammation Pathways and Cell-Cell Interactions in Alcohol-Associated Liver Disease.

Authors:  Elise Slevin; Leonardo Baiocchi; Nan Wu; Burcin Ekser; Keisaku Sato; Emily Lin; Ludovica Ceci; Lixian Chen; Sugeily R Lorenzo; Wenjuan Xu; Konstantina Kyritsi; Victoria Meadows; Tianhao Zhou; Debiyoti Kundu; Yuyan Han; Lindsey Kennedy; Shannon Glaser; Heather Francis; Gianfranco Alpini; Fanyin Meng
Journal:  Am J Pathol       Date:  2020-09-11       Impact factor: 4.307

Review 10.  Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors.

Authors:  Sven Francque; Gyongyi Szabo; Manal F Abdelmalek; Christopher D Byrne; Kenneth Cusi; Jean-François Dufour; Michael Roden; Frank Sacks; Frank Tacke
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-10-22       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.